When cachexia status was classified using a 4-stage system 32, we find that patients with PCa can be differentiated from NCa patients by CRP, TIMP-1 and GDF-15 (Figure 2B, Table S6). This evidence concerns the gene GDF15 and posterior cortical atrophy.